.png){kind=logo}
GC Asia
UCB launches Eu2bn refi facility
Belgian biopharma group UCB has launched a Eu2bn loan to refinance part of the debt it took on to buy German rival Schwarz Pharma in 2006.
The facility is split into a Eu500m 364 day term loan and a Eu1.5bn three year revolver with an optional one year extension. The deal is being co-ordinated by BNP Paribas Fortis, Commerzbank and Mizuho.
The loan will partly refinance a Eu4bn acquisition facility taken out by UCB ...Already a subscriber? Login
-
Latest news from Securitization
-
Use of blocker subsidiaries to blunt tax impact increases in CLOs
24 Sep 2020 -
Securitization issuers ready rush to market ahead of election uncertainty
24 Sep 2020 -
EC’s fresh push for Capital Markets Union seeks unified data platform
24 Sep 2020 -
RMBS unemployment impact delayed but not stopped, data shows
24 Sep 2020 -
Funding Circle lifts lid on struggles in UK SME lending
24 Sep 2020
-
-
Latest news from Securitization
-
Use of blocker subsidiaries to blunt tax impact increases in CLOs
24 Sep 2020 -
Securitization issuers ready rush to market ahead of election uncertainty
24 Sep 2020 -
EC’s fresh push for Capital Markets Union seeks unified data platform
24 Sep 2020 -
RMBS unemployment impact delayed but not stopped, data shows
24 Sep 2020 -
Funding Circle lifts lid on struggles in UK SME lending
24 Sep 2020
-
